Plague News and Research

RSS

Extremely infectious pneumonia-like disease slips through body's immune system

A new study found that an extremely infectious pneumonia-like disease in humans slips through the immune system's usual defense mechanisms.

21 Dec 2005

Megestrol acetate may combat weight loss during radiation treatments

A new study by researchers at Wake Forest University Baptist Medical Center and colleagues shows that a drug originally used to treat breast cancer may help combat the severe weight loss that can plague patients undergoing radiation treatment for lung and head and neck cancer.

28 Nov 2005

$230 billion in health care spending nationally is devoted to insurance administration

Billing and insurance paperwork consume at least one out of every five dollars of private insurance health spending in California, according to a new study by health policy researchers.

14 Nov 2005

New report identifies over 40 infectious agents that pose significant human health problems in the United States or abroad

Vaccines have helped eradicate and tame some of history's worst infectious diseases, but there are many more diseases out there that vaccines can help overcome. The challenges society needs to confront to unlock the future promise of vaccines against the plagues of the 21st century are the focus of a new report by the American Academy of Microbiology.

9 Oct 2005

Online education program improved physicians' knowledge about the diagnosis and management of diseases caused by bioterrorism

In the event of a biologic attack, physicians will be first responders and represent the front line of defense, but little is known about the ability of physicians to appropriately diagnose and treat patients infected with bioterrorism agents, according to background information in the article.

27 Sep 2005

Previously unknown family of plague virulence factors identified

Researchers at Duke University Medical Center have identified a previously unknown family of virulence factors that make the bacterium responsible for the plague especially efficient at killing its host.

28 Aug 2005

New phenomenon in which one bacterial cell can stop the growth of another on physical contact

Scientists have discovered a new phenomenon in which one bacterial cell can stop the growth of another on physical contact. The bacteria that stop growing may go into a dormant state, rather than dying. The findings have implications for management of chronic diseases, such as urinary tract infections.

22 Aug 2005

C. elegans has similar virus-fighting mechanism as humans and can be used in research

Researchers at the University of California, Riverside have discovered that a simple worm, called C. elegans, makes an excellent experimental host for studying some of the most virulent viruses that infect humans.

17 Aug 2005

Two studies reveal how plague disables immune system

Two studies by researchers at the University of Chicago show how the bacteria that cause the plague manage to outsmart the immune system and how, by slightly altering one of the microbe's tools, the researchers produced what may be the first safe and effective vaccine.

1 Aug 2005

Product claiming to protect against anthrax lacks credentials or approval

The U.S. Food and Drug Administration says Bio-Germ, a lotion being promoted by a Texas businessman lacks federal approval and could face scrutiny for claims made on its Web site.

5 Jul 2005

The bacteria that cause food poisoning, bubonic plague, and whooping cough all deploy the same weapon to infect the body

A molecular "syringe" sticks out of the bacteria, pokes a hole in a nearby cell, and squirts in venomous proteins that hijack the cell's machinery.

2 Jun 2005

New WHO rules mean countries could face quarantine in bid to beat killer epidemics

Under new rules agreed by the World Health Organisation yesterday (WHO), serious outbreaks of deadly diseases such as bird flu and SARS could mean travel and trade restrictions could be placed on many countries.

24 May 2005

New regulations to tackle disease outbreaks given the red light by the WHO

The recent outbreaks of communicable diseases such as SARS and avian flu in particular, have prompted the United Nations health agency’s policy-making body to adopt a new set of regulations concerning responses from Governments and international bodies when new diseases emerge and old ones reappear.

23 May 2005

New set of International Health Regulations to manage public health emergencies of international concern

Today, the World Health Assembly approved a new set of International Health Regulations to manage public health emergencies of international concern. The new rules will "prevent, protect against, control and provide a public health response to the international spread of disease."

23 May 2005

New combination vaccine effective against plague

Plague, a bacterium that ravaged Europe in the Middle Ages and is today one of the most feared potential agents of bio-terrorism, may have met its match, according to Wake Forest University School of Medicine scientists.

18 May 2005

World Health Assembly hears warning on avian influenza threat

The 58th World Health Assembly heard a warning from Dr. LEE Jong-wook, Director-General of the World Health Organization, on what he called the "most serious known health threat the world is facing today, which is avian influenza."

18 May 2005

Rifaximin is effective in preventing attacks of diarrhea

An antibiotic can be safely used to prevent attacks of diarrhea that plague millions of globe-trotting vacationers and business travelers, a Houston research team reports this week in the Annals of Internal Medicine.

17 May 2005

Humans more prone to cancer than chimpanzees

Chimpanzees and humans share a common ancestor, and even today 99 percent of the two species' DNA is identical. But since the paths of man and chimp diverged 5 million years ago, that one percent of genetic difference appears to have changed humans in an unexpected way: It could have made people more prone to cancer.

15 May 2005

NIAID has awarded 10 grants and 2 contracts totaling approximately $27 million to fund development of new therapeutics and vaccines against bioterrorism

The National Institute of Allergy and Infectious Diseases (NIAID) has awarded 10 grants and 2 contracts totaling approximately $27 million to fund development of new therapeutics and vaccines against some of the most deadly agents of bioterrorism including anthrax, botulinum toxin, Ebola virus, pneumonic plague, smallpox and tularemia.

11 May 2005

Trauma a frequent experience on American Indian reservations

American Indians living on reservations are at high risk for being exposed to such trauma as witnessing a loved one's death or being the victim of a physical attack, according to research comparing trauma on two American Indian reservations to that in the general U.S. population.

27 Apr 2005